
    
      All patients received an oral contraceptive pill with 0.030 mg of ethinyl-estradiol and 3.0
      mg of drospirenone the cycle prior to ovarian stimulation. On the second day of menstruation,
      patients started ovarian stimulation as follows:

      Patients < 36: 225 IU/day of recombinant FSH (FSH alone group) or 150 IU of rFSH and 75 IU of
      rLH/day (FSH+LH group) for 5 days. On day 6, a 0.25 mg/day dose of the GnRH antagonist
      Cetrorelix is added until the day of rCG administration.

      Patients 36-39: Initial dose of 300 IU of rFSH /day (FSH alone group)) or 225 IU of rFSH and
      75 IU of rLH/day (FSH + LH group) for 5 days. On day 6, a 0.25 mg/day dose of the GnRH
      antagonist Cetrorelix is added until the day of rCG administration.

      A maximum of 3 embryos were transferred on day 3 of embryo development.
    
  